期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Did pediatric drug development advance epilepsy treatment in young patients?It is time for new research goals
1
作者 Earl B Ettienne Emilio Russo +2 位作者 Pasquale Striano Jane M Grant-Kels Klaus Rose 《World Journal of Methodology》 2024年第2期65-74,共10页
Modern drugs have changed epilepsy,which affects people of all ages.However,for young people with epilepsy,the framework of drug development has stalled.In the wake of the thalidomide catastrophe,the misconception eme... Modern drugs have changed epilepsy,which affects people of all ages.However,for young people with epilepsy,the framework of drug development has stalled.In the wake of the thalidomide catastrophe,the misconception emerged that for people<18 years of age drugs,including antiseizure medications(ASMs),need separate proof of efficacy and safety,overall called"pediatric drug development".For ASMs,this has changed to some degree.Authorities now accept that ASMs are effective in<18 years as well,but they still require"extrapolation of efficacy,"as if minors were another species.As a result,some of the pediatric clinical epilepsy research over the past decades was unnecessary.Even more importantly,this has hampered research on meaningful research goals.We do not need to confirm that ASMs work before as they do after the 18th birthday.Instead,we need to learn how to prevent brain damage in young patients by preventing seizures and optimize ASMs’uses.Herein we discuss how to proceed in this endeavor. 展开更多
关键词 EPILEPSY pediatric drug development Therapeutic orphans Antiseizure medications pediatric investigation plan Clinical pharmacology
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部